BDH Industries Ltd
Incorporated in 1935, BDH Industries Ltd manufactures therapeutic formulations covering wide range of pharmaceuticals[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Domestic Revenue ₹ In Lakhs ・Standalone data |
|
|||||||||||
| Export Revenue ₹ In Lakhs ・Standalone data |
||||||||||||
| Number of Employees Number ・Standalone data |
||||||||||||
| Installed Wind Power Capacity MW ・Standalone data |
||||||||||||
| Electrical Energy Generated (Wind) kWh ・Standalone data |
||||||||||||
| Gross Current Asset (GCA) Days Days ・Standalone data |
||||||||||||
| R&D Expenditure (Percentage of Turnover) % ・Standalone data |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1d - We are enclosing herewith the Audited Standalone Financial Results for the quarter and year ended on 31st March 2026 of the financial year 2025-26 published …
-
Announcement under Regulation 30 (LODR)-Meeting Updates
2d - Board approved FY26 audited results, recommended Rs5 dividend, set AGM for 14 Aug 2026, and reported unmodified audit opinion.
-
Corporate Action-Board approves Dividend
2d - Board approved FY26 audited results, recommended Rs.5 dividend, fixed 14 Aug 2026 AGM, appointed auditors.
- Audited Standalone Financial Results For The Fourth Quarter And Year Ended On 31St March 2026 Of The Financial Year 2025-26. 2d
-
Board Meeting Outcome for Outcome Of Board Meeting
2d - FY26 audited standalone results approved; Rs5 dividend recommended; AGM on 14 Aug 2026; unmodified audit opinion.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
BDHIL is a full-service Contract Manufacturing Organization for production of Pharmaceutical, Oncological Products and associated packaging services. It is an exporter and manufacturer of therapeutic formulations covering a wide range of pharmaceuticals